WDR35 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.845200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.454400E-01
Normal-vs-Stage2
2.569400E-01
Normal-vs-Stage3
1.600630E-01
Normal-vs-Stage4
5.103400E-01
Stage1-vs-Stage2
2.147600E-02
Stage1-vs-Stage3
2.388200E-02
Stage1-vs-Stage4
8.083000E-01
Stage2-vs-Stage3
1.608730E-04
Stage2-vs-Stage4
2.138200E-02
Stage3-vs-Stage4
1.715160E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.281800E-01
Normal-vs-AfricanAmerican
5.943200E-01
Normal-vs-Asian
1.128560E-01
Caucasian-vs-AfricanAmerican
9.041400E-01
Caucasian-vs-Asian
1.124040E-01
AfricanAmerican-vs-Asian
1.725840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.099600E-01
Normal-vs-Female
5.918200E-01
Male-vs-Female
4.437600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.507400E-01
Normal-vs-Age(41-60Yrs)
7.233600E-01
Normal-vs-Age(61-80Yrs)
4.156800E-01
Normal-vs-Age(81-100Yrs)
1.903170E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.454000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.345200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.628400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.584400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.344550E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.547000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.806400E-01
Normal-vs-Daily Drinker
2.887200E-01
Normal-vs-Weekly Drinker
2.049000E-01
Normal-vs-Occasional Drinker
9.713200E-01
Normal-vs-Social Drinker
8.708400E-01
Non Drinker-vs-Daily Drinker
8.067800E-01
Non Drinker-vs-Weekly Drinker
9.142800E-01
Non Drinker-vs-Occasional Drinker
9.062300E-02
Non Drinker-vs-Social Drinker
1.900820E-01
Daily Drinker-vs-Weekly Drinker
7.722400E-01
Daily Drinker-vs-Occasional Drinker
1.340010E-01
Daily Drinker-vs-Social Drinker
2.209800E-01
Weekly Drinker-vs-Occasional Drinker
9.856000E-02
Weekly Drinker-vs-Social Drinker
2.022400E-01
Occasional Drinker-vs-Social Drinker
7.390200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.757830E-01
Normal-vs-Grade 2
2.916000E-02
Normal-vs-Grade 3
1.669870E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.385400E-01
Grade 1-vs-Grade 3
3.793600E-01
Grade 1-vs-Grade 4
1.757830E-01
Grade 2-vs-Grade 3
5.327800E-01
Grade 2-vs-Grade 4
2.916000E-02
Grade 3-vs-Grade 4
1.669870E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.170400E-01
Normal-vs-NonDiabetic
5.003800E-01
Diabetic-vs-NonDiabetic
2.979600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.788610E-01
Normal-vs-NoPancreatitis
4.571000E-01
Pancreatitis-vs-NoPancreatitis
4.151800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.741000E-01
Normal-vs-N1
2.849200E-01
N0-vs-N1
2.340600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.179400E-01
Normal-vs-TP53-NonMutant
9.882800E-01
TP53-Mutant-vs-TP53-NonMutant
1.100150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
